• Latest Posts
In Depth 6 Oct 2023

Will the U.S. Cancer Moonshot program land its target to halve cancer death rates?  

Five impactful biotech companies to know in New York

U.S. approval for psychedelic drug MDMA nears after success in clinic

ADVERTISEMENT
In Depth 4 Sep 2023

The biggest private biotech investments in August 2023

Five North Carolina biotech companies making their mark

Are these 10 biotech recruiters on your radar this year?

Moleculin issues acute myeloid leukemia drug data

Crossbow Therapeutics launches with $80M to target cancer

ADVERTISEMENT